Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: An observational study

Roy F. Chemaly, Harrys A. Torres, Elizabeth A. Aguilera, Gloria Mattiuzzi, Maria Cabanillas, Hagop M. Kantarjian, Virginia Gonzalez, Amar Safdar, Issam I. Baad

Research output: Contribution to journalReview articlepeer-review

46 Scopus citations

Abstract

We reviewed the records of 33 patients with leukemia who experienced influenza during the period from October 2000 to March 2004. Three (38%) of the 8 patients who did not receive neuraminidase inhibitor therapy and none of the 25 patients who received it died of influenza pneumonia (P = .001). The use of neuraminidase inhibitor therapy seems to improve the outcome of influenza in patients with leukemia.

Original languageEnglish (US)
Pages (from-to)964-967
Number of pages4
JournalClinical Infectious Diseases
Volume44
Issue number7
DOIs
StatePublished - Apr 1 2007

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: An observational study'. Together they form a unique fingerprint.

Cite this